X4 Pharmaceuticals Reports First-Quarter 2023 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
06 23 21 -- How To Educate Payers And Reduce Your Risk Of Failure clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.
02.15.21 How Ionis Pharmaceuticals Is Advancing Multiple Late-Stage Trials During COVID
YPrime eCOA Platform Isn’t it about time for a globally proven eCOA technology that gives you peace of mind? One that provides a better user experience for patients, sites and sponsors? YPrime’s eCOA platform delivers even the most complex protocol seamlessly. Developed to integrate intelligently with your other technologies, all modalities are available for site- or home-based trials and paired with secure web backup for guaranteed accuracy and confident, informed decision-making.
It’s Time for the Prime eCOA Solution: It’s Time for YPrime.
Featured Editorial
By Ed Miseta, chief editor, Clinical Leader
12.16.20 FDA s Office Of Minority Health And Health Equity Addresses Patient Diversity
AVROBIO president and CEO Geoff MacKay tells
Business of Biotech about the technology his company is using to drive at-scale gene therapy production for lysosomal disorders and how they overcame a major manufacturing investment that didn t quite work as planned. Listen now and subscribe so you never miss an episode.
Featured Editorial
By Ed Miseta, chief editor, Clinical Leader
The diversity of patients participating in clinical trials continues to be a problem in drug development. As sponsors and sites attempt to address the problem, regulators are also doing their best to address the issue. One person deeply involved in this issue is Rear Admiral Richardae Araojo, the associate commissioner for minority health and director of the Office of Minority Health and Health Equity at the FDA.